MOORX
Price
$18.37
Change
+$0.23 (+1.27%)
Updated
Jun 2 closing price
Net Assets
573.83M
VRTIX
Price
$450.82
Change
+$4.04 (+0.90%)
Updated
Jun 2 closing price
Net Assets
16.58B
Interact to see
Advertisement

MOORX vs VRTIX

Header iconMOORX vs VRTIX Comparison
Open Charts MOORX vs VRTIXBanner chart's image
MOORX vs VRTIX Comparison Chart in %
View a ticker or compare two or three
VS
MOORX vs. VRTIX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MOORX is a Buy and VRTIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VRTIX has more cash in the bank: 16.6B vs. MOORX (574M). VRTIX pays higher dividends than MOORX: VRTIX (1.07) vs MOORX (0.21). MOORX was incepted earlier than VRTIX: MOORX (12 years) vs VRTIX (15 years). MOORX (1.10) is less costly to investors than VRTIX (0.05). MOORX is a more actively managed with annual turnover of: 40.00 vs. VRTIX (14.00). MOORX has a lower initial minimum investment than VRTIX: MOORX (0) vs VRTIX (5000000). VRTIX annual gain was more profitable for investors over the last year : 40.83 vs. MOORX (11.88). VRTIX return over 5 years is better than : 29.82 vs. MOORX (-0.56).
MOORXVRTIXMOORX / VRTIX
Total Expense Ratio1.100.052,200%
Annual Report Gross Expense Ratio1.100.052,200%
Fund Existence12 years15 years-
Gain YTD11.22017.42364%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets574M16.6B3%
Annual Yield % from dividends0.211.0720%
Returns for 1 year11.8840.8329%
Returns for 3 years22.1560.6537%
Returns for 5 years-0.5629.82-2%
Returns for 10 years41.46160.3426%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SSRM29.81-0.01
-0.03%
SSR Mining
BMR1.94-0.05
-2.51%
Beamr Imaging Ltd
SPGI417.46-11.10
-2.59%
S&P Global
ARQQ16.27-0.69
-4.07%
Arqit Quantum Inc
BCAX19.63-0.99
-4.80%
Bicara Therapeutics Inc.